Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C168580
http://purl.obolibrary.org/obo/NCIT_C168580
|
|---|---|
| Preferred Name | Bispecific Antibody AMG 509 |
| Definitions |
A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 509 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 509 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response. |
|---|---|
| prefLabel | Bispecific Antibody AMG 509
|
| label | Bispecific Antibody AMG 509
|
| NCI_META_CUI | CL972905
|
| PDQ_Closed_Trial_Search_ID | 800690
|
| code | C168580
|
| Has_Target | |
| prefixIRI | NCIT:C168580
|
| in_subset |
See more
See less
|
| Display_Name | Bispecific Antibody AMG 509
|
| Preferred_Name | Bispecific Antibody AMG 509
|
| Contributing_Source | CTRP
|
| Maps_To | Bispecific Antibody AMG 509
|
| NCI_Drug_Dictionary_ID | 800690
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 800690
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |